Based on SEC filing data. A pharmaceutical company based in College Park, MD that raised $250,000 through a convertible note in its pre-seed stage. Founded in 2014, the corporation is in early-stage development.
Get notified the moment Calabash Bioscience, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.